MLchartDataset catalogue

anti-VEGF anticalin PRS-050-PEG40

Term · Oncology and biomedicine · MLC-T-ONC-011170

A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth.

Table 1. Record
IdentifierMLC-T-ONC-011170
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011170",
  "term": "anti-VEGF anticalin PRS-050-PEG40",
  "field": "Oncology and biomedicine",
  "definition": "A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-vegf-anticalin-prs-050-peg40/"
}

Record 2,320 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.